Reference | 1: Tulstrup M, Frandsen TL, Abrahamsson J, Lund B, Vettenranta K, Jonsson OG,
Marquart HVH, Albertsen BK, Heyman M, Schmiegelow K; Nordic Society of Paediatric
Haematology and Oncology (NOPHO). Individualized 6-mercaptopurine increments in
consolidation treatment of childhood acute lymphoblastic leukemia: a NOPHO
randomized controlled trial. Eur J Haematol. 2017 Oct 6. doi: 10.1111/ejh.12979.
[Epub ahead of print] PubMed PMID: 28983968.
<br>
2: Singh M, Bhatia P, Khera S, Trehan A. Emerging role of NUDT15 polymorphisms in
6-mercaptopurine metabolism and dose related toxicity in acute lymphoblastic
leukaemia. Leuk Res. 2017 Sep 25;62:17-22. doi: 10.1016/j.leukres.2017.09.012.
[Epub ahead of print] Review. PubMed PMID: 28963908.
<br>
3: Sierpe R, Noyong M, Simon U, Aguayo D, Huerta J, Kogan MJ, Yutronic N.
Construction of 6-thioguanine and 6-mercaptopurine carriers based on
βcyclodextrins and gold nanoparticles. Carbohydr Polym. 2017 Dec 1;177:22-31.
doi: 10.1016/j.carbpol.2017.08.102. Epub 2017 Aug 25. PubMed PMID: 28962762.
<br>
4: Satsangi J, Kennedy NA, Mowat C, Arnott I, Keerie C, Lewis S, Ennis H. A
randomised, double-blind, parallel-group trial to assess mercaptopurine versus
placebo to prevent or delay recurrence of Crohn’s disease following surgical
resection (TOPPIC). Southampton (UK): NIHR Journals Library; 2017 Sep.
PubMed PMID: 28949459.
<br>
5: Chen XX, Shen SH. [Research advances in pharmacogenomics of mercaptopurine].
Zhongguo Dang Dai Er Ke Za Zhi. 2017 Sep;19(9):1027-1033. Chinese. PubMed PMID:
28899477.
<br>
6: Tanaka Y. Susceptibility to 6-mercaptopurine toxicity related with NUDT15 and
ABCC4 variants in Japanese childhood acute lymphoblastic leukemia. Rinsho
Ketsueki. 2017;58(8):950-956. doi: 10.11406/rinketsu.58.950. Japanese. PubMed
PMID: 28883280.
<br>
7: Kim H, Seo H, Park Y, Min BJ, Seo ME, Park KD, Shin HY, Kim JH, Kang HJ. APEX1
Polymorphism and Mercaptopurine-Related Early Onset Neutropenia in Pediatric
Acute Lymphoblastic Leukemia. Cancer Res Treat. 2017 Sep 4. doi:
10.4143/crt.2017.351. [Epub ahead of print] PubMed PMID: 28882023.
<br>
8: Alsous M, Abu Farha R, Alefishat E, Al Omar S, Momani D, Gharabli A, McElnay
J, Horne R, Rihani R. Adherence to 6-Mercaptopurine in children and adolescents
with Acute Lymphoblastic Leukemia. PLoS One. 2017 Sep 6;12(9):e0183119. doi:
10.1371/journal.pone.0183119. eCollection 2017. PubMed PMID: 28877179; PubMed
Central PMCID: PMC5587295.
<br>
9: Correction to /6-Mercaptopurine Decreases the Bcl-2/Bax Ratio and Induces
Apoptosis in Activated Splenic B Lymphocytes/. Mol Pharmacol. 2017 Oct;92(4):500.
doi: 10.1124/mol.111.513err. PubMed PMID: 28874608.
<br>
10: Friedman S, Larsen MD, Magnussen B, Jølving LR, de Silva P, Nørgård BM.
Paternal use of azathioprine/6-mercaptopurine or methotrexate within 3 months
before conception and long-term health outcomes in the offspring-A nationwide
cohort study. Reprod Toxicol. 2017 Oct;73:196-200. doi:
10.1016/j.reprotox.2017.08.013. Epub 2017 Aug 24. PubMed PMID: 28844800.
|